Literature DB >> 18605954

Can both EDTA and citrate plasma samples be used in measurements of fibrinogen and C-reactive protein concentrations?

Mika Skeppholm1, N Håkan Wallén, Margareta Blombäck, Anders Kallner.   

Abstract

BACKGROUND: Fibrinogen and C-reactive protein (CRP) concentrations are predictors of outcome in the atherosclerotic patient. It is important in risk stratification that these quantities are measured reproducibly in routine and research.
METHOD: In the present study, we compare measurements of fibrinogen and high-sensitivity CRP in EDTA and citrate plasma samples (n=150) using nephelometric immunoassays. Fibrinogen was also measured in citrate plasma using a clotting method.
RESULTS: In approximately one-third of the samples, the fibrinogen concentration measured by immunoassay was higher in citrate plasma than in EDTA plasma, in spite of the dilution by citrate. The immunoassay results of fibrinogen concentration measurements in EDTA and citrate plasma differed significantly and also differed from those of functionally measured fibrinogen concentrations. A difference was found between the concentration of CRP in EDTA plasma and citrated plasma which also did not correspond to the dilution.
CONCLUSIONS: Reproducibility of results is essential in risk stratification by fibrinogen or high-sensitivity CRP concentrations and small differences close to the decision limits may have a decisive impact. Immunological measurements are liable to confounding effects that may be difficult to foresee, qualitatively and quantitatively. Great care should be observed when measuring the concentration of calcium containing analytes in anticoagulated samples. Fibrinogen concentrations should preferably be measured functionally in citrate plasma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18605954     DOI: 10.1515/CCLM.2008.219

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

1.  Levels and determinants of inflammatory biomarkers in a Swiss population-based sample (CoLaus study).

Authors:  Pedro Marques-Vidal; Murielle Bochud; François Bastardot; Thomas Lüscher; François Ferrero; Jean-Michel Gaspoz; Fred Paccaud; Adrian Urwyler; Roland von Känel; Christoph Hock; Gérard Waeber; Martin Preisig; Peter Vollenweider
Journal:  PLoS One       Date:  2011-06-09       Impact factor: 3.240

2.  Evidence for chronic low-grade systemic inflammation in individuals with agoraphobia from a population-based prospective study.

Authors:  En-Young N Wagner; Jan T Wagner; Jennifer Glaus; Caroline L Vandeleur; Enrique Castelao; Marie-Pierre F Strippoli; Peter Vollenweider; Martin Preisig; Roland von Känel
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

3.  Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation.

Authors:  Brittany B Dennis; M Constantine Samaan; Monica Bawor; James Paul; Carolyn Plater; Guillaume Pare; Andrew Worster; Michael Varenbut; Jeff Daiter; David C Marsh; Dipika Desai; Lehana Thabane; Zainab Samaan
Journal:  Neuropsychiatr Dis Treat       Date:  2014-11-19       Impact factor: 2.570

4.  A step beyond the hygiene hypothesis-immune-mediated classes determined in a population-based study.

Authors:  Vladeta Ajdacic-Gross; Margot Mutsch; Stephanie Rodgers; Anja Tesic; Mario Müller; Erich Seifritz; En-Young N Wagner; Roland von Känel; Markus A Landolt; Nina Steinemann; Viktor von Wyl; Enrique Castelao; Marie-Pierre F Strippoli; Jennifer Glaus; Caroline Vandeleur; Pedro M Marques-Vidal; Peter Vollenweider; Martin Preisig
Journal:  BMC Med       Date:  2019-04-09       Impact factor: 8.775

5.  A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration.

Authors:  Paul S de Vries; Daniel I Chasman; Maria Sabater-Lleal; Ming-Huei Chen; Jennifer E Huffman; Maristella Steri; Weihong Tang; Alexander Teumer; Riccardo E Marioni; Vera Grossmann; Jouke J Hottenga; Stella Trompet; Martina Müller-Nurasyid; Jing Hua Zhao; Jennifer A Brody; Marcus E Kleber; Xiuqing Guo; Jie Jin Wang; Paul L Auer; John R Attia; Lisa R Yanek; Tarunveer S Ahluwalia; Jari Lahti; Cristina Venturini; Toshiko Tanaka; Lawrence F Bielak; Peter K Joshi; Ares Rocanin-Arjo; Ivana Kolcic; Pau Navarro; Lynda M Rose; Christopher Oldmeadow; Helene Riess; Johanna Mazur; Saonli Basu; Anuj Goel; Qiong Yang; Mohsen Ghanbari; Gonneke Willemsen; Ann Rumley; Edoardo Fiorillo; Anton J M de Craen; Anne Grotevendt; Robert Scott; Kent D Taylor; Graciela E Delgado; Jie Yao; Annette Kifley; Charles Kooperberg; Rehan Qayyum; Lorna M Lopez; Tina L Berentzen; Katri Räikkönen; Massimo Mangino; Stefania Bandinelli; Patricia A Peyser; Sarah Wild; David-Alexandre Trégouët; Alan F Wright; Jonathan Marten; Tatijana Zemunik; Alanna C Morrison; Bengt Sennblad; Geoffrey Tofler; Moniek P M de Maat; Eco J C de Geus; Gordon D Lowe; Magdalena Zoledziewska; Naveed Sattar; Harald Binder; Uwe Völker; Melanie Waldenberger; Kay-Tee Khaw; Barbara Mcknight; Jie Huang; Nancy S Jenny; Elizabeth G Holliday; Lihong Qi; Mark G Mcevoy; Diane M Becker; John M Starr; Antti-Pekka Sarin; Pirro G Hysi; Dena G Hernandez; Min A Jhun; Harry Campbell; Anders Hamsten; Fernando Rivadeneira; Wendy L Mcardle; P Eline Slagboom; Tanja Zeller; Wolfgang Koenig; Bruce M Psaty; Talin Haritunians; Jingmin Liu; Aarno Palotie; André G Uitterlinden; David J Stott; Albert Hofman; Oscar H Franco; Ozren Polasek; Igor Rudan; Pierre-Emmanuel Morange; James F Wilson; Sharon L R Kardia; Luigi Ferrucci; Tim D Spector; Johan G Eriksson; Torben Hansen; Ian J Deary; Lewis C Becker; Rodney J Scott; Paul Mitchell; Winfried März; Nick J Wareham; Annette Peters; Andreas Greinacher; Philipp S Wild; J Wouter Jukema; Dorret I Boomsma; Caroline Hayward; Francesco Cucca; Russell Tracy; Hugh Watkins; Alex P Reiner; Aaron R Folsom; Paul M Ridker; Christopher J O'Donnell; Nicholas L Smith; David P Strachan; Abbas Dehghan
Journal:  Hum Mol Genet       Date:  2015-11-10       Impact factor: 6.150

6.  Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. the CoLaus study.

Authors:  Pedro Marques-Vidal; Rémy Schmid; Murielle Bochud; François Bastardot; Roland von Känel; Fred Paccaud; Jennifer Glaus; Martin Preisig; Gérard Waeber; Peter Vollenweider
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

7.  Associations of Personality Traits With Chronic Low-Grade Inflammation in a Swiss Community Sample.

Authors:  En-Young N Wagner; Vladeta Ajdacic-Gross; Marie-Pierre F Strippoli; Mehdi Gholam-Rezaee; Jennifer Glaus; Caroline Vandeleur; Enrique Castelao; Peter Vollenweider; Martin Preisig; Roland von Känel
Journal:  Front Psychiatry       Date:  2019-11-12       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.